Guides concerning tenofovir exposure via breastfeeding: A comparison of drug dosages by developmental stage
Tenofovir disoproxil fumarate (TDF) is a prodrug of tenofovir, and after being administered orally, it converts to tenofovir in the blood. With the increasing use of TDF in women for treatment and prevention of mother-to-child transmission (MTCT) of both human immunodeficiency virus (HIV) and hepati...
Main Authors: | Xiaotong Hu, Liming Wang, Fujie Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-10-01
|
Series: | International Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S120197121930308X |
Similar Items
-
Tenofovir Pre-exposure Prophylaxis for Pregnant and Breastfeeding Women at Risk of HIV Infection: The Time is Now.
by: Lynne M Mofenson
Published: (2016-09-01) -
Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir
by: Giuseppe Coppolino, et al.
Published: (2017-03-01) -
Approaches to tenofovir and abacavir drug shortages in South Africa: A guide for clinicians
by: Laurie Schowalter, et al.
Published: (2012-06-01) -
Tenofovir induced lichenoid drug eruption
by: Mrinal Gupta, et al.
Published: (2015-07-01) -
Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue
by: Laura Else, et al.
Published: (2022-06-01)